GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Berry Genomics Co Ltd (SZSE:000710) » Definitions » Additional Paid-In Capital

Berry Genomics Co (SZSE:000710) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2025)


View and export this data going back to 1997. Start your Free Trial

What is Berry Genomics Co Additional Paid-In Capital?


Berry Genomics Co's quarterly additional paid-in capital increased from Sep. 2024 (¥0 Mil) to Dec. 2024 (¥822 Mil) but then stayed the same from Dec. 2024 (¥822 Mil) to Mar. 2025 (¥0 Mil).

Berry Genomics Co's annual additional paid-in capital stayed the same from Dec. 2022 (¥822 Mil) to Dec. 2023 (¥822 Mil) and stayed the same from Dec. 2023 (¥822 Mil) to Dec. 2024 (¥822 Mil).


Berry Genomics Co Additional Paid-In Capital Historical Data

The historical data trend for Berry Genomics Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Berry Genomics Co Additional Paid-In Capital Chart

Berry Genomics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 881.01 821.57 821.57 821.57 821.57

Berry Genomics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 821.57 - 821.57 -

Berry Genomics Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Berry Genomics Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Berry Genomics Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Berry Genomics Co Business Description

Traded in Other Exchanges
N/A
Address
Life Park Road, Building 5, Courtyard 4, Science and Technology Park, Changping District, Beijing, CHN
Berry Genomics Co Ltd is a biotechnology company. It providess gene sequencing detection equipment and services.
Executives
Gao Yang Directors, executives
Hou Ying Directors, executives
Wang Yu Jing Supervisors
Wang Dong Directors, executives
Zhou Dai Xing Directors, executives
Ou Yang Xiang Yu Supervisors
Li Guang Chao Independent director
Gu Zhong Guo Directors, executives
Wen Wu Director
Ding Xian Xing Supervisors

Berry Genomics Co Headlines

No Headlines